person

Jerome M. B.

Country: France
Department: Oncology

Research Overview

assignment

Clinical Trials ·

Palazestrant and Ribociclib versus Letrozole and Ribociclib for First-line Treatment of ER+/HER2- Advanced Breast Cancer
Sacituzumab Tirumotecan With or Without Bevacizumab Versus Standard of Care in Patients With Newly Diagnosed Advanced HRD-Negative Ovarian Cancer Following Platinum-Based Chemotherapy
TAILORswitch (PADA-2): ctDNA‑guided switch to camizestrant plus abemaciclib in ER‑positive HER2‑negative metastatic breast cancer

location_city

Research Sites

Data & Insights

medical_services

Primary Speciality

Main therapeutic area

handshake

Return Partnerships

Recurring site collaborations

496

Sites with multiple studies

Has run more than one trial at 496 of 830 partner sites.

Specializations

Gastrointestinal Oncology

Specializes in advanced treatments for colorectal cancer and biliary tract cancers, with particular focus on personalized therapeutic approaches and targeted treatments.

Colon carcinoma management
Metastatic colorectal cancer therapy
Advanced biliary cancer treatment
Upper gastrointestinal tract malignancies

Breast Cancer Research

Conducts extensive research in breast cancer treatment, particularly focusing on hormone receptor-positive and triple-negative breast cancer variants.

HR+/HER2- breast cancer therapy
Triple-negative breast cancer treatment
Metastatic breast cancer management
Early-stage breast cancer interventions

Innovative Treatment Approaches

Explores cutting-edge therapeutic strategies including immunotherapy and molecular targeted therapies across various cancer types.

Circulating tumor DNA analysis
Targeted molecular therapies
Combination treatment strategies
Novel drug development research

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.